Clinical trial
Intravitreal Bevacizumab for Management of Active Progressive Proliferative…
NCT00370721 · Shahid Beheshti University of Medical Sciences, Other · Unknown status
Key facts
| NCT number | NCT00370721 |
|---|---|
| Title | Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR) |
| Lead sponsor | Shahid Beheshti University of Medical Sciences, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | bevacizumab |
| Start date | Mar 1, 2006 |
| First posted | Sep 1, 2006 |
| Last update posted | Jun 26, 2008 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: